HR 3731
Small Biotech Innovation Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:10 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Small Biotech Innovation Act, proposes an exception to Medicare’s drug price negotiation program for small biotechnology manufacturers. Specifically, it would exclude certain ‘qualifying single source drugs’ – drugs produced by these manufacturers – from being subject to negotiation starting in 2029. The bill defines ‘small biotech manufacturer’ based on factors like the number of drugs produced and investment in research and development, aiming to protect innovation within the industry.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.